Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-427-7 | CAS number: -
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study without detailed documentation
Data source
Reference
- Reference Type:
- publication
- Title:
- Investigations on the effects of alkylpolyglucosides on development and fertility
- Author:
- H. Messinger, W. Aulmann, M. Kleber, W. Koehl
- Year:
- 2 007
- Bibliographic source:
- Food and Chemical Toxicology 45 (2007) 1375-1382
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- Version / remarks:
- 27th July 1995
- GLP compliance:
- not specified
- Limit test:
- yes
Test material
- Reference substance name:
- Alkylpolyglucosides C12-14 fatty alcohol
- IUPAC Name:
- Alkylpolyglucosides C12-14 fatty alcohol
- Test material form:
- not specified
Constituent 1
- Specific details on test material used for the study:
- Limited details on test substance might also be described as D-Glucopyranose, Oligomeric, C10-16 Alkyl Glycosides
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: no information
- Age at study initiation: no information
- Weight at study initiation: no information
- Fasting period before study: no information
- Housing: 5 animals per sex per cage
- Diet: ad libitum (commercially available laboratory rodent diet)
- Water: ad libitum
- Acclimation period: no information
ENVIRONMENTAL CONDITIONS
- Temperature: 21°C (+/- 2°C)
- Humidity: 55 % (+/-10 %)
- Air changes (per hr): 15-20
- Photoperiod (hrs dark / hrs light): 12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Details on mating procedure:
- - M/F ratio per cage: no information
- Length of cohabitation: nop information
- Proof of pregnancy: vaginal plug / sperm in vaginal smear
- Further matings after two unsuccessful attempts: no information - Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- Prior to mating, throughout the gestation (22 days) and lactation period until post mortem day 3.
- Details on study schedule:
- - Age at mating of the mated animals in the study: 14 weeks
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day
- Remarks:
- Control group
- Dose / conc.:
- 100 mg/kg bw/day
- Dose / conc.:
- 300 mg/kg bw/day
- Dose / conc.:
- 1 000 mg/kg bw/day
- No. of animals per sex per dose:
- 10
- Control animals:
- yes
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: No data
DETAILED CLINICAL OBSERVATIONS: Yes
BODY WEIGHT: Yes
OTHER: Effects related to reproduction and hormone balance such as estrous cycle, mating performance, pregnancy rates and the number of embryo resorptions are registered. Pup losses are recorded and the filial generation is examined for behavioural abnormalities and external growth abnormalities. - Oestrous cyclicity (parental animals):
- Estrous cycle was monitored.
- Sperm parameters (parental animals):
- Parameters examined in P male parental generations:
testis weight, epididymis weight
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
Effect levels (P0)
- Key result
- Dose descriptor:
- NOEL
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- clinical signs
- mortality
- body weight and weight gain
- organ weights and organ / body weight ratios
- reproductive function (oestrous cycle)
- reproductive function (sperm measures)
- reproductive performance
Target system / organ toxicity (P0)
- Key result
- Critical effects observed:
- no
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
Effect levels (F1)
- Key result
- Dose descriptor:
- NOEL
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- clinical signs
Target system / organ toxicity (F1)
- Key result
- Critical effects observed:
- no
Overall reproductive toxicity
- Key result
- Reproductive effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- No adverse effects were observed in all test animals at all doses, the highest dose being 1000 mg/kg/d.
- Executive summary:
The reproductive toxicity of the substance was assessed in a an OECD 421 reproductive screening study. Sprague-Dawley rats were randomly assigned to four groups the animals of which were administered with the substance by gavage with 0, 100, 300 and 1000 mg/kg/d. Treatment commenced when males and females were approximately 12 weeks of age, 2 weeks before pairing and continuously thereafter, up to the day before sacrifice (study day 53, day 4 post mortem).
No effects indicative of general toxicity are observed in parental animals. Relative and absolute weights of testes, epididymides, and seminal vesicles do not differ between test substance and control animals. A marginal reduction is seen in absolute and relative prostate weights in all treated males compared to the control group. A significant difference is found for the low dose group only and no dosedependency was found. Therefore, this finding is not considered to be substance related. With regard to reproductive parameters, no test substance related symptoms are observed. One female in the mid-dose group and two females in the high-dose group did not mate until day 10 and were mated with another male afterwards. One female in the high dose group did not mate after a period of 20 days. Mean litter weights, mean pup weights, sex ratios and gestation periods are similar among all groups. Some slight variations in pre-birth loss are seen in the high-dose group although no significant differences to the controls is found. Clinical signs do not show treatment related effects on pre-weaning pups nor do necropsy reveal any effects in decedent or Fl pups. There is no difference between treated and control animals as assessed by macroscopic examination. No adverse effects were observed regarding male and female reproductive organs even at the very high dose of 1000 mg/kg bw/day. So a NOEL of 1000 mg/kg/day can be established.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
